Literature DB >> 15567306

Solid-state characterization and dissolution properties of naproxen-arginine-hydroxypropyl-beta-cyclodextrin ternary system.

Paola Mura1, Gian Piero Bettinetti, Marzia Cirri, Francesca Maestrelli, Milena Sorrenti, Laura Catenacci.   

Abstract

The effect of ternary complexation of naproxen, a poorly water soluble anti-inflammatory drug, with hydroxypropyl-beta-cyclodextrin and the basic aminoacid L-arginine on the drug dissolution properties has been investigated. Equimolar binary (drug-cyclodextrin or drug-arginine) and ternary (drug-cyclodextrin-arginine) systems were prepared by blending, cogrinding, coevaporation, and characterized by differential scanning calorimetry, thermogravimetric analysis, FT-IR spectroscopy, X-ray diffractometry. The dissolution behavior of naproxen from the different products was evaluated by means of a continuous flow through method. The results of solid state studies indicated the presence of strong interactions between the components in ternary coevaporated and coground systems, which were both of totally amorphous nature. In contrast, the presence of either free drug or free arginine was detected when the third component (cyclodextrin or aminoacid) was physically mixed, respectively, to the drug-arginine binary system (as physical mixture, coevaporate, or coground product) or to the drug-cyclodextrin binary system (as physical mixture, coevaporate, or coground product). All ternary combinations were significantly (P<0.001) more effective than the corresponding binary drug-cyclodextrin and drug-arginine systems in improving the naproxen dissolution rate. The best performance in this respect was given by the ternary coevaporate, with about 15 times increase in terms of both drug relative dissolution rate and dissolution efficiency. The synergistic effect of the simultaneous use of arginine and cyclodextrin on the dissolution rate of naproxen was attributed to the combined effects of inclusion in cyclodextrin and salt formation, as well as to a specific role played by arginine in this interaction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15567306     DOI: 10.1016/j.ejpb.2004.05.005

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  11 in total

1.  Moringa coagulant as a stabilizer for amorphous solids: Part I.

Authors:  Santosh Bhende; Namdeo Jadhav
Journal:  AAPS PharmSciTech       Date:  2012-02-23       Impact factor: 3.246

2.  Interaction of artesunate with β-cyclodextrin: Characterization, thermodynamic parameters, molecular modeling, effect of PEG on complexation and antimalarial activity.

Authors:  Renu Chadha; Sushma Gupta; Geeta Shukla; D V S Jain; Raghuvir R S Pissurlenkar; Evans C Coutinho
Journal:  Results Pharma Sci       Date:  2011-08-04

3.  The role of L-arginine in inclusion complexes of omeprazole with cyclodextrins.

Authors:  Ana Figueiras; Jorge M G Sarraguça; Alberto A C C Pais; Rui A Carvalho; J Francisco Veiga
Journal:  AAPS PharmSciTech       Date:  2010-02-05       Impact factor: 3.246

4.  Solid-state characterization and dissolution properties of meloxicam-moringa coagulant-PVP ternary solid dispersions.

Authors:  Suhail B Noolkar; Namdeo R Jadhav; Santosh A Bhende; Suresh G Killedar
Journal:  AAPS PharmSciTech       Date:  2013-03-13       Impact factor: 3.246

5.  Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose.

Authors:  Paloma Marina de la Torre-Iglesias; Juan José García-Rodriguez; Guillermo Torrado; Susana Torrado; Santiago Torrado-Santiago; Francisco Bolás-Fernández
Journal:  Drug Des Devel Ther       Date:  2014-09-18       Impact factor: 4.162

6.  Improving co-amorphous drug formulations by the addition of the highly water soluble amino Acid, proline.

Authors:  Katrine Tarp Jensen; Korbinian Löbmann; Thomas Rades; Holger Grohganz
Journal:  Pharmaceutics       Date:  2014-07-14       Impact factor: 6.321

7.  Inclusion complexes of cefuroxime axetil with β-cyclodextrin: Physicochemical characterization, molecular modeling and effect of l-arginine on complexation.

Authors:  Sarika Sapte; Yogesh Pore
Journal:  J Pharm Anal       Date:  2016-04-01

8.  Betulin complex in γ-cyclodextrin derivatives: properties and antineoplasic activities in in vitro and in vivo tumor models.

Authors:  Codruta Soica; Cristina Dehelean; Corina Danciu; Hai Ming Wang; Gerhard Wenz; Rita Ambrus; Florina Bojin; Mariana Anghel
Journal:  Int J Mol Sci       Date:  2012-11-15       Impact factor: 5.923

9.  Changes in the Physicochemical Properties of Piperine/β-Cyclodextrin due to the Formation of Inclusion Complexes.

Authors:  Toshinari Ezawa; Yutaka Inoue; Sujimon Tunvichien; Rina Suzuki; Ikuo Kanamoto
Journal:  Int J Med Chem       Date:  2016-02-22

Review 10.  Grinding as Solvent-Free Green Chemistry Approach for Cyclodextrin Inclusion Complex Preparation in the Solid State.

Authors:  Mario Jug; Paola Angela Mura
Journal:  Pharmaceutics       Date:  2018-10-16       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.